432 filings
Page 3 of 22
NT 10-Q
osj8 6whgenjdxn
15 Aug 22
Notice of late quarterly filing
8:00am
8-K
xk2 barpv1
18 Jul 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
0jnp8vp4xh8fs
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:51pm
8-K
9lbzy0i
25 May 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:59pm
8-K
ca33rzf4g1qv
20 May 22
Unaudited Pro Forma Condensed Combined Financial Statements
4:30pm
8-K
04e4du24
16 May 22
Other Events
4:36pm
8-K
rt7x8atx1svzeywr
16 May 22
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights
8:30am
424B4
e3pwgthzii78 bc91r
12 May 22
Prospectus supplement with pricing info
9:12am
EFFECT
hjiud39
10 May 22
Notice of effectiveness
12:15am
CORRESP
o135986 l9wlymzud
5 May 22
Correspondence with SEC
12:00am
UPLOAD
jrswo95
4 May 22
Letter from SEC
12:00am
8-K
7ug l6h65z15ty0lf3c
8 Apr 22
Entry into a Material Definitive Agreement
7:00pm
424B5
khyhnydn4 rv8fryx6bx
8 Apr 22
Prospectus supplement for primary offering
6:15pm
8-K
2617jp4
1 Mar 22
Vyant Bio Issues Letter to Shareholders
8:30am
8-K
1psip3id9wc jzg
24 Jan 22
Departure of Directors or Certain Officers
9:00am